Tamie Chilcote

Biography

Tamie Chilcote, Ph.D., co-founder and COO, has over 21 years of experience in target discovery & validation, and drug discovery & development.  Prior to co-founding ActiveSite, she was a Principal Scientist at Elan Pharmaceuticals (previously Athena Neurosciences).  Dr. Chilcote led team efforts on both Alzheimer’s and Parkinson’s Disease at Elan.  Importantly, she identified disease-specific modifications of the Parkinson’s Disease protein alpha-synuclein, and specific antibodies directed to alpha-synuclein, one of which is in clinical development.  Dr. Chilcote has over 20 publications and is an inventor on 14 US patents.  Dr. Chilcote has a B.S. and Ph.D. in biochemistry from the Pennsylvania State University (State College, PA, USA).

Research Interest

 target discovery & validation, and drug discovery & development